Mumps virus SH protein inhibits NF-κB activation by interacting with tumor necrosis factor receptor 1, interleukin-1 receptor 1, and Toll-like receptor 3 complexes

Journal of Virology

Volumn 91, Issue 18, 2017, Pages

  Franz, Stephanie ^a   Rennert, Paul ^a   Woznik, Maria ^a,b   Grützke, Josephine ^a   Lüdde, Amy ^a   Pais, Eva Maria Arriero ^a   Finsterbusch, Tim ^a,c   Geyer, Henriette ^a,d   Mankertz, Annette ^a   Friedrich, Nicole ^a  

^a ROBERT KOCH INSTITUTE   (Germany)

^b QIAGEN GMBH   (Germany)

^c Sebia   (Germany)

^d Octapharma   (Germany)

Author keywords

Mumps; NF B; Paramyxovirus

Indexed keywords

IL1R1 PROTEIN, HUMAN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1 RECEPTOR TYPE I; SMALL HYDROPHOBIC PROTEIN, MUMPS VIRUS; TLR3 PROTEIN, HUMAN; TOLL LIKE RECEPTOR 3; TUMOR NECROSIS FACTOR RECEPTOR 1; VIRAL PROTEIN;

ANIMAL; ANTAGONISTS AND INHIBITORS; CELL LINE; HOST PATHOGEN INTERACTION; HUMAN; IMMUNOLOGY; METABOLISM; MUMPS VIRUS;

ANIMALS; CELL LINE; HOST-PATHOGEN INTERACTIONS; HUMANS; MUMPS VIRUS; NF-KAPPA B; RECEPTORS, INTERLEUKIN-1 TYPE I; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE I; TOLL-LIKE RECEPTOR 3; VIRAL PROTEINS;

EID: 85028326284     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.01037-17     Document Type: Article

References (57)

1. Hviid A, Rubin S, Muhlemann K. 2008. Mumps. Lancet 371:932-944. https://doi.org/10.1016/S0140-6736(08)60419-5
2. Rubin S, Eckhaus M, Rennick LJ, Bamford CG, Duprex WP. 2015. Molecular biology, pathogenesis and pathology of mumps virus. J Pathol 235:242-252. https://doi.org/10.1002/path.4445
3. Galazka AM, Robertson SE, Kraigher A. 1999. Mumps and mumps vaccine: a global review. Bull World Health Organ 77:3-14
4. van Loon FP, Holmes SJ, Sirotkin BI, Williams WW, Cochi SL, Hadler SC, Lindegren ML. 1995. Mumps surveillance-United States, 1988-1993. MMWR CDC Surveill Summ 44:1-14
5. Davidkin I, Kontio M, Paunio M, Peltola H. 2010. MMR vaccination and disease elimination: the Finnish experience. Expert Rev Vaccines 9:1045-1053. https://doi.org/10.1586/erv.10.99
6. Borgmann S, Schwab F, Santibanez S, Mankertz A. 2014. Mumps virus infection in vaccinated patients can be detected by an increase in specific IgG antibodies to high titres: a retrospective study. Epidemiol Infect 142:2388-2396. https://doi.org/10.1017/S0950268813003427
7. Eriksen J, Davidkin I, Kafatos G, Andrews N, Barbara C, Cohen D, Duks A, Griskevicius A, Johansen K, Bartha K, Kriz B, Mitis G, Mossong J, Nardone A, O'Flanagan D, De Ory F, Pistol A, Theeten H, Prosenc K, Slacikova M, Pebody R. 2013. Seroepidemiology of mumps in Europe (1996-2008): why do outbreaks occur in highly vaccinated populations? Epidemiol Infect 141:651-666. https://doi.org/10.1017/S0950268812001136
8. Mankertz A, Beutel U, Schmidt FJ, Borgmann S, Wenzel JJ, Ziegler P, Weissbrich B, Santibanez S. 2015. Laboratory-based investigation of suspected mumps cases submitted to the German National Reference Centre for Measles, Mumps, and Rubella, 2008 to 2013. Int J Med Microbiol 305:619-626. https://doi.org/10.1016/j.ijmm.2015.08.011
9. Okajima K, Iseki K, Koyano S, Kato A, Azuma H. 2013. Virological analysis of a regional mumps outbreak in the northern island of Japan-mumps virus genotyping and clinical description. Jpn J Infect Dis 66:561-563. https://doi.org/10.7883/yoken.66.561
10. Otto W, Mankertz A, Santibanez S, Saygili H, Wenzel J, Jilg W, Wieland W, Borgmann S. 2010. Ongoing outbreak of mumps affecting adolescents and young adults in Bavaria, Germany, August to October 2010. Euro Surveill 15:19748
11. Watson-Creed G, Saunders A, Scott J, Lowe L, Pettipas J, Hatchette TF. 2006. Two successive outbreaks of mumps in Nova Scotia among vaccinated adolescents and young adults. CMAJ 175:483-488. https://doi.org/10.1503/cmaj.060660
12. Takeuchi K, Tanabayashi K, Hishiyama M, Yamada A, Sugiura A. 1991. Variations of nucleotide sequences and transcription of the SH gene among mumps virus strains. Virology 181:364-366. https://doi.org/10.1016/0042-6822(91)90504-5
13. Johansson B, Tecle T, Orvell C. 2002. Proposed criteria for classification of new genotypes of mumps virus. Scand J Infect Dis 34:355-357. https:// doi.org/10.1080/00365540110080043
14. WHO. 2012. Mumps virus nomenclature update: 2012. Wkly Epidemiol Rec 87:217-224
15. Jin L, Orvell C, Myers R, Rota PA, Nakayama T, Forcic D, Hiebert J, Brown KE. 2015. Genomic diversity of mumps virus and global distribution of the 12 genotypes. Rev Med Virol 25:85-101. https://doi.org/10.1002/rmv.1819
16. Takeuchi K, Tanabayashi K, Hishiyama M, Yamada A. 1996. The mumps virus SH protein is a membrane protein and not essential for virus growth. Virology 225:156-162. https://doi.org/10.1006/viro.1996.0583
17. Bukreyev A, Whitehead SS, Murphy BR, Collins PL. 1997. Recombinant respiratory syncytial virus from which the entire SH gene has been deleted grows efficiently in cell culture and exhibits site-specific attenuation in the respiratory tract of the mouse. J Virol 71:8973-8982
18. He B, Leser GP, Paterson RG, Lamb RA. 1998. The paramyxovirus SV5 small hydrophobic (SH) protein is not essential for virus growth in tissue culture cells. Virology 250:30-40. https://doi.org/10.1006/viro.1998.9354
19. Lin Y, Bright AC, Rothermel TA, He B. 2003. Induction of apoptosis by paramyxovirus simian virus 5 lacking a small hydrophobic gene. J Virol 77:3371-3383. https://doi.org/10.1128/JVI.77.6.3371-3383.2003
20. Biacchesi S, Skiadopoulos MH, Yang L, Lamirande EW, Tran KC, Murphy BR, Collins PL, Buchholz UJ. 2004. Recombinant human metapneumovirus lacking the small hydrophobic SH and/or attachment G glycoprotein: deletion of G yields a promising vaccine candidate. J Virol 78: 12877-12887. https://doi.org/10.1128/JVI.78.23.12877-12887.2004
21. Xu P, Li Z, Sun D, Lin Y, Wu J, Rota PA, He B. 2011. Rescue of wild-type mumps virus from a strain associated with recent outbreaks helps to define the role of the SH ORF in the pathogenesis of mumps virus. Virology 417:126-136. https://doi.org/10.1016/j.virol.2011.05.003
22. Wilson RL, Fuentes SM, Wang P, Taddeo EC, Klatt A, Henderson AJ, He B. 2006. Function of small hydrophobic proteins of paramyxovirus. J Virol 80:1700-1709. https://doi.org/10.1128/JVI.80.4.1700-1709.2006
23. Verstrepen L, Bekaert T, Chau TL, Tavernier J, Chariot A, Beyaert R. 2008. TLR-4, IL-1R and TNF-R signaling to NF-kappaB: variations on a common theme. Cell Mol Life Sci 65:2964-2978. https://doi.org/10.1007/s00018-008-8064-8
24. Doyle SL, O'Neill LA. 2006. Toll-like receptors: from the discovery of NFkappaB to new insights into transcriptional regulations in innate immunity. Biochem Pharmacol 72:1102-1113. https://doi.org/10.1016/j.bcp.2006.07.010
25. Hoshino K, Takeuchi O, Kawai T, Sanjo H, Ogawa T, Takeda Y, Takeda K, Akira S. 1999. Cutting edge: Toll-like receptor 4 (TLR4)-deficient mice are hyporesponsive to lipopolysaccharide: evidence for TLR4 as the Lps gene product. J Immunol 162:3749-3752
26. Alexopoulou L, Holt AC, Medzhitov R, Flavell RA. 2001. Recognition of double-stranded RNA and activation of NF-kappaB by Toll-like receptor 3. Nature 413:732-738. https://doi.org/10.1038/35099560
27. Gilmore TD. 2006. Introduction to NF-kappaB: players, pathways, perspectives. Oncogene 25:6680-6684. https://doi.org/10.1038/sj.onc.1209954
28. Karin M, Ben-Neriah Y. 2000. Phosphorylation meets ubiquitination: the control of NF-[kappa]B activity. Annu Rev Immunol 18:621-663. https:// doi.org/10.1146/annurev.immunol.18.1.621
29. Sakurai H, Chiba H, Miyoshi H, Sugita T, Toriumi W. 1999. IkappaB kinases phosphorylate NF-kappaB p65 subunit on serine 536 in the transactivation domain. J Biol Chem 274:30353-30356. https://doi.org/10.1074/jbc.274.43.30353
30. Katze MG, Fornek JL, Palermo RE, Walters KA, Korth MJ. 2008. Innate immune modulation by RNA viruses: emerging insights from functional genomics. Nat Rev Immunol 8:644-654. https://doi.org/10.1038/nri2377
31. Banerjee AK, Barik S, De BP. 1991. Gene expression of nonsegmented negative strand RNA viruses. Pharmacol Ther 51:47-70. https://doi.org/ 10.1016/0163-7258(91)90041-J
32. Kolakofsky D, Pelet T, Garcin D, Hausmann S, Curran J, Roux L. 1998. Paramyxovirus RNA synthesis and the requirement for hexamer genome length: the rule of six revisited. J Virol 72:891-899
33. Malik T, Shegogue CW, Werner K, Ngo L, Sauder C, Zhang C, Duprex WP, Rubin S. 2011. Discrimination of mumps virus small hydrophobic gene deletion effects from gene translation effects on virus virulence. J Virol 85:6082-6085. https://doi.org/10.1128/JVI.02686-10
34. Fuentes S, Tran KC, Luthra P, Teng MN, He B. 2007. Function of the respiratory syncytial virus small hydrophobic protein. J Virol 81: 8361-8366. https://doi.org/10.1128/JVI.02717-06
35. Li Z, Xu J, Patel J, Fuentes S, Lin Y, Anderson D, Sakamoto K, Wang LF, He B. 2011. Function of the small hydrophobic protein of J paramyxovirus. J Virol 85:32-42. https://doi.org/10.1128/JVI.01673-10
36. Taylor G, Wyld S, Valarcher JF, Guzman E, Thom M, Widdison S, Buchholz UJ. 2014. Recombinant bovine respiratory syncytial virus with deletion of the SH gene induces increased apoptosis and pro-inflammatory cytokines in vitro, and is attenuated and induces protective immunity in calves. J Gen Virol 95:1244-1254. https://doi.org/10.1099/vir.0.064931-0
37. Bao X, Kolli D, Liu T, Shan Y, Garofalo RP, Casola A. 2008. Human metapneumovirus small hydrophobic protein inhibits NF-kappaB transcriptional activity. J Virol 82:8224-8229. https://doi.org/10.1128/JVI.02584-07
38. Ofengeim D, Yuan J. 2013. Regulation of RIP1 kinase signalling at the crossroads of inflammation and cell death. Nat Rev Mol Cell Biol 14: 727-736. https://doi.org/10.1038/nrm3683
39. Cao Z, Henzel WJ, Gao X. 1996. IRAK: a kinase associated with the interleukin-1 receptor. Science 271:1128-1131. https://doi.org/10.1126/ science.271.5252.1128
40. Tanabe M, Kurita-Taniguchi M, Takeuchi K, Takeda M, Ayata M, Ogura H, Matsumoto M, Seya T. 2003. Mechanism of up-regulation of human Toll-like receptor 3 secondary to infection of measles virus-attenuated strains. Biochem Biophys Res Commun 311:39-48. https://doi.org/10.1016/j.bbrc.2003.09.159
41. Croston GE, Cao Z, Goeddel DV. 1995. NF-kappa B activation by interleukin-1 (IL-1) requires an IL-1 receptor-associated protein kinase activity. J Biol Chem 270:16514-16517. https://doi.org/10.1074/jbc.270.28.16514
42. Chow JC, Young DW, Golenbock DT, Christ WJ, Gusovsky F. 1999. Toll-like receptor-4 mediates lipopolysaccharide-induced signal transduction. J Biol Chem 274:10689-10692. https://doi.org/10.1074/jbc.274.16.10689
43. Aliprantis AO, Yang RB, Mark MR, Suggett S, Devaux B, Radolf JD, Klimpel GR, Godowski P, Zychlinsky A. 1999. Cell activation and apoptosis by bacterial lipoproteins through toll-like receptor-2. Science 285:736-739. https://doi.org/10.1126/science.285.5428.736
44. Sarkar SN, Smith HL, Rowe TM, Sen GC. 2003. Double-stranded RNA signaling by Toll-like receptor 3 requires specific tyrosine residues in its cytoplasmic domain. J Biol Chem 278:4393-4396. https://doi.org/10.1074/jbc.C200655200
45. Rudd BD, Burstein E, Duckett CS, Li X, Lukacs NW. 2005. Differential role for TLR3 in respiratory syncytial virus-induced chemokine expression. J Virol 79:3350-3357. https://doi.org/10.1128/JVI.79.6.3350-3357.2005
46. Weber C, Muller C, Podszuweit A, Montino C, Vollmer J, Forsbach A. 2012. Toll-like receptor (TLR) 3 immune modulation by unformulated small interfering RNA or DNA and the role of CD14 (in TLR-mediated effects). Immunology 136:64-77. https://doi.org/10.1111/j.1365-2567.2012.03559.x
47. Hiebert SW, Paterson RG, Lamb RA. 1985. Identification and predicted sequence of a previously unrecognized small hydrophobic protein, SH, of the paramyxovirus simian virus 5. J Virol 55:744-751
48. Hiebert SW, Richardson CD, Lamb RA. 1988. Cell surface expression and orientation in membranes of the 44-amino-acid SH protein of simian virus 5. J Virol 62:2347-2357
49. Olmsted RA, Collins PL. 1989. The 1A protein of respiratory syncytial virus is an integral membrane protein present as multiple, structurally distinct species. J Virol 63:2019-2029
50. van den Hoogen BG, Bestebroer TM, Osterhaus AD, Fouchier RA. 2002. Analysis of the genomic sequence of a human metapneumovirus. Virology 295:119-132. https://doi.org/10.1006/viro.2001.1355
51. Kyte J, Doolittle RF. 1982. A simple method for displaying the hydropathic character of a protein. J Mol Biol 157:105-132. https://doi.org/10.1016/0022-2836(82)90515-0
52. Artimo P, Jonnalagedda M, Arnold K, Baratin D, Csardi G, de Castro E, Duvaud S, Flegel V, Fortier A, Gasteiger E, Grosdidier A, Hernandez C, Ioannidis V, Kuznetsov D, Liechti R, Moretti S, Mostaguir K, Redaschi N, Rossier G, Xenarios I, Stockinger H. 2012. ExPASy: SIB bioinformatics resource portal. Nucleic Acids Res 40:W597-W603. https://doi.org/10.1093/nar/gks400
53. Russell RF, McDonald JU, Ivanova M, Zhong Z, Bukreyev A, Tregoning JS. 2015. Partial attenuation of respiratory syncytial virus with a deletion of a small hydrophobic gene is associated with elevated interleukin-1beta responses. J Virol 89:8974-8981. https://doi.org/10.1128/JVI.01070-15
54. Rubin SA, Pletnikov M, Carbone KM. 1998. Comparison of the neurovirulence of a vaccine and a wild-type mumps virus strain in the developing rat brain. J Virol 72:8037-8042
55. Visvanathan KV, Goodbourn S. 1989. Double-stranded RNA activates binding of NF-kappa B to an inducible element in the human betainterferon promoter. EMBO J 8:1129-1138
56. Woznik M, Rodner C, Lemon K, Rima B, Mankertz A, Finsterbusch T. 2010. Mumps virus small hydrophobic protein targets ataxin-1 ubiquitin-like interacting protein (ubiquilin 4). J Gen Virol 91:2773-2781. https://doi.org/10.1099/vir.0.024638-0
57. Ishida T, Mizushima S, Azuma S, Kobayashi N, Tojo T, Suzuki K, Aizawa S, Watanabe T, Mosialos G, Kieff E, Yamamoto T, Inoue J. 1996. Identification of TRAF6, a novel tumor necrosis factor receptor-associated factor protein that mediates signaling from an amino-terminal domain of the CD40 cytoplasmic region. J Biol Chem 271:28745-28748. https://doi.org/ 10.1074/jbc.271.46.28745